{"id":"W1966679991","doi":"10.1016/j.clon.2013.08.011","title":"Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial","year":2013,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Taxane; Breast cancer; Metastatic breast cancer; Adjuvant; Docetaxel; Adjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001429007,0.0006375384,0.002102965,0.0001506876,0.0001934612,0.00002946852,0.000458346,0.0008871494,0.00412588],"category_scores_gemma":[0.0009589557,0.0003816856,0.001211725,0.0002979958,0.001030119,0.0001100169,0.0001590119,0.001308286,0.00016732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003004348,"about_ca_system_score_gemma":0.001894099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001278451,"about_ca_topic_score_gemma":0.0004599094,"domain_scores_codex":[0.9925515,0.001626687,0.002533133,0.001330775,0.0008986812,0.00105923],"domain_scores_gemma":[0.9938203,0.002907386,0.0007912803,0.001117005,0.000743371,0.0006206282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5364832,0.01163159,0.0499545,0.0001304726,0.001285428,0.0001845544,0.001681135,0.000002232385,0.0007387127,0.00003733608,0.02148014,0.3763907],"study_design_scores_gemma":[0.1261904,0.06435663,0.7996702,0.0005142671,0.0003038591,0.00004031181,0.0001646047,0.00002088096,0.001803683,0.0001450003,0.006431275,0.0003588327],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665158,0.0005338836,0.000009524942,0.01958819,0.001744361,0.008627168,0.002075928,0.0000572486,0.0008478791],"genre_scores_gemma":[0.9854932,0.001117582,0.0004875528,0.001908724,0.002082101,0.005958631,0.0001054835,0.0001135865,0.002733172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7497157,"threshold_uncertainty_score":0.9998635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1271280895894067,"score_gpt":0.4545716326262476,"score_spread":0.3274435430368408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}